U.S. pharma giant copyright scrapped two experimental weight loss products past yr—a at the time-every day capsule, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-daily capsule, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has expla